Abstract
Due to an oversight on the part of the authors in Current Medicinal Chemistry, 2013, 20(1), 144-157 of article entitled “Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer” by Dulinska-Litewka J, McCubrey JA and Laidler P, one slip-up was encountered. The project number assigned by the Commission to research UJCM was unfortunately not written completely. To close accounting on this project on each of the presented abstracts from International Meeting - Conferences, publications and chapters in books, the number assigned by the NCN must be given.
The number which was published was K/PBW/ 000561 but it should have been K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38). The correct acknowledgement section of my manuscript should be as follows:
Current Medicinal Chemistry
Title:ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.
Volume: 21 Issue: 32
Author(s): Joanna Dulinska-Litewka
Affiliation:
Abstract: Due to an oversight on the part of the authors in Current Medicinal Chemistry, 2013, 20(1), 144-157 of article entitled “Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer” by Dulinska-Litewka J, McCubrey JA and Laidler P, one slip-up was encountered. The project number assigned by the Commission to research UJCM was unfortunately not written completely. To close accounting on this project on each of the presented abstracts from International Meeting - Conferences, publications and chapters in books, the number assigned by the NCN must be given.
The number which was published was K/PBW/ 000561 but it should have been K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38). The correct acknowledgement section of my manuscript should be as follows:
Export Options
About this article
Cite this article as:
Dulinska-Litewka Joanna, ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157., Current Medicinal Chemistry 2014; 21 (32) . https://dx.doi.org/10.2174/092986732132140930102757
DOI https://dx.doi.org/10.2174/092986732132140930102757 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy
Current Molecular Medicine Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology
Current Radiopharmaceuticals Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines
Current Molecular Pharmacology Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Current Medicinal Chemistry A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal Chemistry Beta-Emitting Radionuclides for Peptide Receptor Radionuclide Therapy
Current Topics in Medicinal Chemistry Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Current Pharmaceutical Design Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery
Current Drug Delivery Chemosensitization by Antisense Oligonucleotides Targeting MDM2
Current Cancer Drug Targets Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions
Current Cancer Drug Targets Establishment of Conditionally Immortalized Cell Lines with Specific Functions and its Application to Differential Gene Expression Analysis by DNA Microarray Technology
Current Pharmaceutical Analysis MDM2 Inhibitors for Pancreatic Cancer Therapy
Mini-Reviews in Medicinal Chemistry CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review
Protein & Peptide Letters Approaches for the Cure of Type 1 Diabetes by Cellular and Gene Therapy
Current Gene Therapy Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disordersǂ
Mini-Reviews in Organic Chemistry Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways
Current Pharmaceutical Design Efficient Silencing of Hepatitis B Virus by Helper-dependent Adenovirus Vector-mediated Delivery of Artificial Antiviral Primary Micro RNAs
MicroRNA 2015 Update of Erectile Dysfunction Management Following Radical Prostatectomy: From Basic Research to Clinical Management
Current Pharmaceutical Design